Clinical trial · Observational
The Experience of TYAC Offered Ovarian Tissue Cryopreservation
An Interpretative Phenomenological Analysis Study Into the Experience of Teenagers and Young Adults Who Have Been Offered Ovarian Tissue Cryopreservation Prior to Cancer Treatment.
NCT02830061CI-TRIAL-00041291completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study looks at the experiences of teenagers and young adults who have been offered ovarian tissue cryopreservation prior to cancer treatment as a result of their cancer and/or cancer treatment putting them at moderate-to-high risk of premature ovarian failure.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Fertility | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interviews | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- TYAC
- description
- Teenagers and young adults who have received a cancer diagnosis which puts them at moderate-to-high risk of fertility impairment. Semi-structured interviews will take place with each individual participant.
- interventionNames
- Other: Interviews
Primary outcomes (1)
- measure
- Individual semi-structured interviews about the experiences of Teenagers and Young Adults with Cancer undergoing OTC
- timeFrame
- up to 60 min
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 13 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 11-25 at time of procedure and aged 13+ at time of interview. Due to the short amount of time OTC has been available, there will be no time limit on how long ago the procedure took place. * Received a cancer diagnosis carrying a moderate-high risk of premature ovarian failure as a result of the cancer and/or treatment. * Have been offered ovarian cryopreservation by the ovarian cryopreservation service (participants will be included whether or not they have accepted the procedure). * Has been confirmed as appropriate to approach by the consultant oncologist. Exclusion Criteria: * Under the age of 11 or over the age of 25 at time of procedure. * Under the age of 13 at time of interview. * Received a terminal diagnosis. * The young person is unable to understand their diagnosis and/or fertility options, e.g. those with significant learning disabilities (guidance on this will be sought from the consultant oncologist as part of their approval). * The young person is unaware that the procedure has taken place (guidance on this will be sought from the consultant oncologist as part of their approval).
References
Publications (0)
Data not yet available
No reference posted for this study.